The associations of adipokines with selected markers of the renin-angiotensinogen-aldosterone system: The multi-ethnic study of atherosclerosis

Journal of Human Hypertension

Volumn 29, Issue 2, 2015, Pages 127-133

  Allison, M A ^a   Jenny, N S ^b   McClelland, R L ^c   Cushman, M ^b   Rifkin, D ^a,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; ALDOSTERONE; ANTIHYPERTENSIVE AGENT; LEPTIN; RENIN;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; ASIAN AMERICAN; ATHEROSCLEROSIS; BLOOD PRESSURE REGULATION; DISEASE ASSOCIATION; ETHNICITY; EUROPEAN AMERICAN; FEMALE; HISPANIC; HUMAN; MALE; PLASMA RENIN ACTIVITY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; BLOOD; BODY MASS; ETHNOLOGY; LONGITUDINAL STUDY; MIDDLE AGED;

ADIPONECTIN; AGED; ALDOSTERONE; ANTIHYPERTENSIVE AGENTS; ATHEROSCLEROSIS; BODY MASS INDEX; FEMALE; HUMANS; LEPTIN; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; RENIN; RENIN-ANGIOTENSIN SYSTEM;

EID: 84926207557     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2014.40     Document Type: Article

References (34)

1. Ahima RS. Central actions of adipocyte hormones. Trends Endocrinol Metab 2005; 16: 307-313.
2. Barba G, Russo O, Siani A, Iacone R, Farinaro E, Gerardi MC et al. Plasma leptin and blood pressure in men: graded association independent of body mass and fat pattern. Obes Res 2003; 11: 160-166.
3. Jones DW, Kim JS, Andrew ME, Kim S, Hong YP. Body mass index and blood pressure in Korean men and women: the Korean National Blood Pressure Survey. J Hypertens 1994; 12: 1433-1437.
4. Wofford MR, Hall JE. Pathophysiology and treatment of obesity hypertension. Curr Pharm Des 2004; 10: 3621-3637.
5. Jones DW. Body weight and blood pressure. Effects of weight reduction on hypertension. Am J Hypertens 1996; 9: 50s-54s.
6. Be"towski J. Role of leptin in blood pressure regulation and arterial hypertension. J Hypertens 2006; 24: 789-801.
7. Hausberg M, Morgan DA, Chapleau MA, Sivitz WI, Mark AL, Haynes WG. Differential modulation of leptin-induced sympathoexcitation by baroreflex activation. J Hypertens 2002; 20: 1633-1641.
8. Rahmouni K, Correia MLG, Haynes WG, Mark AL. Obesity-associated hypertension: new insights into mechanisms. Hypertension 2005; 45: 9-14.
9. Haynes WG, Morgan DA, Walsh SA, Mark AL, Sivitz WI. Receptor-mediated regional sympathetic nerve activation by leptin. J Clin Invest 1997; 100: 270-278.
10. Montani J-P, Antic V, Yang Z, Dulloo A. Pathways from obesity to hypertension: from the perspective of a vicious triangle. Int J Obes Relat Metab Disord 2002; 26(Suppl 2): S28-S38.
11. Bild DE, Bluemke DA, Burke GL, Detrano R, Diez Roux AV, Folsom AR et al. Multi-ethnic study of atherosclerosis: objectives and design. Am J Epidemiol 2002; 156: 871-881.
12. Landsberg L, Krieger DR. Obesity, metabolism, and the sympathetic nervous system. Am J Hypertens 1989; 2: 125S-132S.
13. Hall JE, Louis K. Dahl Memorial Lecture. Renal and cardiovascular mechanisms of hypertension in obesity. Hypertension 1994; 23: 381-394.
14. Levey AS, Stevens LA. Estimating GFR using the CKD Epidemiology Collaboration (CKD-EPI) creatinine equation: more accurate GFR estimates, lower CKD prevalence estimates, and better risk predictions. Am J Kidney Dis 2010; 55: 622-627.
15. Criqui MH, Kamineni A, Allison MA, Ix JH, Carr JJ, Cushman M et al. Risk factor differences for aortic versus coronary calcified atherosclerosis: the multiethnic study of atherosclerosis. Arterioscler Thromb Vasc Biol 2010; 30: 2289-2296.
16. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
17. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB et al. Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation 2012; 125: e2-e220.
18. Hall JE. Mechanisms of abnormal renal sodium handling in obesity hypertension. Am J Hypertens 1997; 10: 49S-55S.
19. DiBona GF, Kopp UC. Neural control of renal function. Physiol Rev 1997; 77: 75-197.
20. Flegal KM, Carroll MD, Kit BK, Ogden CL. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA 2012; 307: 491-497.
21. Kelly T, Yang W, Chen C-S, Reynolds K, He J. Global burden of obesity in 2005 and projections to 2030. Int J Obes Relat Metab Disord 2008; 32: 1431-1437.
22. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB et al. Heart disease and stroke statistics-2013 update: a report from the American Heart Association. Circulation 2013; 127: e6-e245.
23. He J, Klag MJ, Appel LJ, Charleston J, Whelton PK. The renin-angiotensin system and blood pressure differences between blacks and whites. Am J Hypertens 1999; 12: 555-562.
24. Richardson SI, Freedman BI, Ellison DH, Rodriguez CJ. Salt sensitivity: a review with a focus on non-Hispanic blacks and Hispanics. J Am Soc Hypertens 2013; 7: 170-179.
25. Correia ML, de G, Haynes WG. Leptin, obesity and cardiovascular disease. Curr Opin Nephrol Hypertens 2004; 13: 215-223.
26. Rahmouni K, Haynes WG, Morgan DA, Mark AL. Selective resistance to central neural administration of leptin in agouti obese mice. Hypertension 2002; 39: 486-490.
27. Pladevall M, Williams K, Guyer H, Sadurn J, Falces C, Ribes A et al. The association between leptin and left ventricular hypertrophy: a population-based crosssectional study. J Hypertens 2006; 24: 1447-1473.
28. Lieb W, Sullivan LM, Aragam J, Harris TB, Roubenoff R, Benjamin EJ et al. Relation of serum leptin with cardiac mass and left atrial dimension in individuals 470 years of age. Am J Cardiol 2009; 104: 602-605.
29. Allison MA, Bluemke DA, McClelland R, Cushman M, Criqui MH, Polak JF et al. Relation of leptin to left ventricular hypertrophy (from the multi-ethnic study of atherosclerosis). Am J Cardiol 2013; 112: 726-730.
30. Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 2005; 115: 911-919.
31. Flynn C, Bakris GL. Interaction between adiponectin and aldosterone. Cardiorenal Med 2011; 1: 96-101.
32. Li P, Zhang XN, Pan CM, Sun F, Zhu DL, Song HD et al. Aldosterone perturbs adiponectin and PAI-1 expression and secretion in 3T3-L1 adipocytes. Horm Metab Res 2011; 43: 464-469.
33. Kotchen TA. Obesity-related hypertension: epidemiology, pathophysiology, and clinical management. Am J Hypertens 2010; 23: 1170-1178.
34. Gu P, Xu A. Interplay between adipose tissue and blood vessels in obesity and vascular dysfunction. Rev Endocr Metab Disord 2013; 14: 49-58.